Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

BioLineRx (BLRX) Revenue: 2023-2025

Historic Revenue for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to $304,000.

  • BioLineRx's Revenue fell 94.36% to $304,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $17.3 million, marking a year-over-year increase of 41.95%. This contributed to the annual value of $28.9 million for FY2024, which is 502.92% up from last year.
  • As of Q2 2025, BioLineRx's Revenue stood at $304,000, which was up 19.22% from $255,000 recorded in Q1 2025.
  • BioLineRx's Revenue's 5-year high stood at $11.7 million during Q4 2024, with a 5-year trough of -$932,000 in Q4 2023.
  • For the 3-year period, BioLineRx's Revenue averaged around $3.2 million, with its median value being $1.1 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first spiked by 1,360.62% in 2024, then crashed by 96.28% in 2025.
  • BioLineRx's Revenue (Quarterly) stood at -$932,000 in 2023, then skyrocketed by 1,360.62% to $11.7 million in 2024, then crashed by 94.36% to $304,000 in 2025.
  • Its Revenue was $304,000 in Q2 2025, compared to $255,000 in Q1 2025 and $11.7 million in Q4 2024.